Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield Complete the Acquisition of Air Lease Corporation April 8, 2026 Sumitomo Corporation, SMBC Aviation Capital, Apollo-managed funds (“Apollo”) and Brookfield today announced that they have completed the previously announced acquisition of Air Lease Corporation (“Air Lease”) and have renamed the business Sumisho Air Lease Corporation (“Sumisho Air Lease”). This transformational transaction improves the financial position of the business with long term support and aviation expertise [...]
ViClarity Launches AI-Powered Reg Monitor to Turn Regulatory Updates into Actionable, Audit-Ready Workflows for Compliance Teams April 8, 2026 New regulatory horizon scanning capability helps compliance teams identify relevant federal and state updates and manage implementation through centralized, auditable workflows
Experian UK&I strengthens its leading digital verification capabilities with the addition of Konfir April 8, 2026 Joining forces enhances Experian’s employment and income verification at scale, improving speed and quality of customer journeys
Oil slides and stocks surge as US hails ‘chance at peace’ April 8, 2026 Global markets breathed a much-needed sigh of relief on Wednesday morning after it emerged Donald Trump reached a temporary ceasefire agreement with Iran, just hours before a high-stakes deadline in which the US president had threatened to destroy bridges, power plants and swathes of Iranian infrastructure. On Tuesday Trump set a dramatic ultimatum that “a [...]
Energy bills threat recedes but retail and hospitality remain on brink April 8, 2026 Retail and hospitality leaders are optimistic that the Iran-US ceasefire could spare them from the worst energy bill shocks, but are urging the government to address an array of other cost pressures. British businesses had warned that the soaring energy prices caused by the war in the Middle East could be devastating if the conflict [...]
Reply Selected by Microsoft as Launch Partner for Agent 365, Supporting the Governance and Scaling of AI agents April 8, 2026 Reply [EXM, STAR: REY] has been confirmed one of a small number of Launch Partners for Agent 365, supporting the general availability of Microsoft’s new platform designed to provide enterprise-grade governance, observability and lifecycle management for AI agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408212380/en/ Microsoft Agent 365 introduces a structured [...]
UK Investors Back Narwhal Labs With £20 Million Investment to Launch DeepBlue Enterprise-Grade Agentic AI April 8, 2026 - Purpose-built for regulated enterprise and government use, DeepBlue OS turns missed customer leads into revenue, deployable in minutes with no setup cost
National insurance and business rate hikes double fault for Queen’s Club profits April 8, 2026 Business rate hikes and increases to employer national insurance have seen profits at Queen’s Club slump by nearly 20 per cent. Hosts of the HSBC Championships – dubbed the precursor to Wimbledon – saw profits before tax fall by 17.2 per cent to £1.96m, down from £2.37m the previous year, on increased revenues of £15.5m. [...]
Rolls-Royce shares boom amid hopes of trade resumption April 8, 2026 Shares in the retail stock darling Rolls-Royce skyrocketed as investors went back to bullish ways on news of a ceasefire in the Middle East. The stock price for the engineering giant soared by as much as 10 per cent as trading opened. It meant the stock hit 1,259.80p. The jump in the share price will [...]
Jeito Capital Hits Record $1.2 Billion (€1 Billion)1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients April 8, 2026 This record closing is the largest raise ever achieved by a fully independent European fund dedicated to Biopharma, validating Jeito’s patient-driven investment strategy, its multidisciplinary, collaborative expertise spanning from science to commercialization of medicines, and value creation In five years, Jeito Capital has tripled its assets under management to €1.6 billion, firmly establishing itself among the top-tier global Biopharma investors Jeito II will build on Jeito I’s proven and differentiated strategy, investing in the most promising clinical Biopharma companies which address unmet patient needs and severe diseases, accelerate breakthrough therapeutic innovation, and deliver transformative benefits for patients This fundraise represents significant momentum for European Biopharma, strengthening its financial firepower and expertise to develop the next generation of global champions